דלג לתוכן
  • Contact Us
  • פייסבוק אתר החברה
Israel Medical Association – The Society for the Study, Prevention, and Treatment of Atherosclerosis
Israel Medical Association – The Society for the Study, Prevention, and Treatment of Atherosclerosis
Israel Medical Association – Society for Research, Prevention and Treatment of Atherosclerosis
  • Home Page
  • About us
  • Conferences
  • Conferences coverage
  • Contact Us
  • Hebrew
  • Home Page
  • About us
  • Conferences
  • Conferences coverage
  • Contact Us
  • Hebrew
Israel Medical Association – The Society for the Study, Prevention, and Treatment of Atherosclerosis
  • Home Page
  • About us
  • Conferences
  • Conferences coverage
  • Contact Us
  • Hebrew
  • Home Page
  • About us
  • Conferences
  • Conferences coverage
  • Contact Us
  • Hebrew
ראשי » 2025 » November (Page 2)

Archive for November 2025

Debate: Case Presentation: Timing and Place of Bempedoic Acid or PCSK9i for ACS Patients with Partial Statin Intolerance

מערכת האתר 24 בNovember 2025 10:52 Comments Off on Debate: Case Presentation: Timing and Place of Bempedoic Acid or PCSK9i for ACS Patients with Partial Statin Intolerance
Read More »

Keynote Lecture: Anti-Atherogenic Effects of Eicosatetraenoic Acid (EPA). Underlying Mechanisms and Clinical Significance

מערכת האתר 24 בNovember 2025 10:48 Comments Off on Keynote Lecture: Anti-Atherogenic Effects of Eicosatetraenoic Acid (EPA). Underlying Mechanisms and Clinical Significance
Read More »

Session 3: Emerging Therapies

מערכת האתר 24 בNovember 2025 10:45 Comments Off on Session 3: Emerging Therapies

Chairpersons: Dov Gavish & Kevin Jon Williams

Read More »

The Effect of SGLT-2 Inhibitor (Empagliflozin) vs Resistance Training or Plant-Based Diet on Functional and Metabolic Aspects in Older Adults with Type 2 Diabetes

מערכת האתר 24 בNovember 2025 10:43 Comments Off on The Effect of SGLT-2 Inhibitor (Empagliflozin) vs Resistance Training or Plant-Based Diet on Functional and Metabolic Aspects in Older Adults with Type 2 Diabetes
Read More »

What did we Learn from the New GLP1 Agonist Trials?

מערכת האתר 24 בNovember 2025 10:40 Comments Off on What did we Learn from the New GLP1 Agonist Trials?
Read More »

“Sweet Dreams? Sleep Challenges in Diabetes”

מערכת האתר 24 בNovember 2025 10:39 Comments Off on “Sweet Dreams? Sleep Challenges in Diabetes”
Read More »

Keynote Lecture: Metabolic Stress is Bad Enough, But Repeated Stress is Even Worse for Atherosclerosis

מערכת האתר 24 בNovember 2025 10:36 Comments Off on Keynote Lecture: Metabolic Stress is Bad Enough, But Repeated Stress is Even Worse for Atherosclerosis
Read More »

Session 2: Diabetes, Coagulation, Platelets and Atherosclerosis

מערכת האתר 24 בNovember 2025 10:33 Comments Off on Session 2: Diabetes, Coagulation, Platelets and Atherosclerosis

Chairpersons: Elena Izkhakov & Jeffrey S. Berger

Read More »

Long-Term Cardiovascular Risk of Elevated Blood Pressure in Adolescents

מערכת האתר 24 בNovember 2025 10:31 Comments Off on Long-Term Cardiovascular Risk of Elevated Blood Pressure in Adolescents
Read More »

Advancements in epidemiology of coronary heart disease: novel methods and risk factors

מערכת האתר 24 בNovember 2025 10:29 Comments Off on Advancements in epidemiology of coronary heart disease: novel methods and risk factors
Read More »
  • 1
  • 2
  • 3
מידע כללי
  • About us
  • Regulations
  • Contact Us
  • ארכיון
לאתר עמותת לכ"ם
לדף הפייסבוק של עמותת לכ"ם

Association Sponsors:

  • Contact Us
  • Regulations
  • Terms of Use
Powered by e-med.co.il
© The Society for the Study, Prevention, and Treatment of Atherosclerosis | All rights reserved

התאמות נגישות

ניתן להשתמש בחצי המקלדת ובמקש Esc לפתיחה וסגירה.

שפה
צבע וניגודיות
התאמות תצוגה
סמן
גודל מלל
0
הגדלת תצוגה
0
מקשי קיצור
  • מקש Esc — פתיחה וסגירה של הסרגל
  • Ctrl + — הגדלת מלל באתר
  • Ctrl − — הקטנת מלל באתר
  • Ctrl 0 — החזרת הגודל המקורי
  • מקש רווח — גלילה כלפי מטה
  • F11 — מסך מלא (לחיצה נוספת מבטלת)
הצגת הצהרת נגישות

דיווח על בעיית נגישות

Scroll to top

Welcome to the website of the Israeli Society for the Research, Prevention, and Treatment of Atherosclerosis.

Access to the site is permitted solely for physicians licensed to practice medicine in Israel
and/or licensed pharmacists and/or individuals who are members of medical or biomedical research staff.